Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03165916 · ClinicalTrials.gov registry record · NA
Study to Compare the Incidence of Biliary Complications After Liver Transplantation
A NA study of Liver Transplant, Complications, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT03165916 is a NA study of Liver Transplant, Complications that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 146 participants, below the 514-participant average among 7 other Liver Transplant, Complications trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03165916, a NA study of Liver Transplant, Complications, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized prospective study will be conducted of patients at Vanderbilt University Medical Center who undergo liver transplantation from March 2014 until approximately 120 patients are randomized. Patients will be randomized to undergo biliary reconstruction with and without stent placement.
Conditions Studied
Interventions
- DEVICE Bard 5 Fr diameter feeding tube
Study Locations (1)
Tennessee
- Vanderbilt Medical Center Liver Transplant Clinic - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2014-09-15 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03165916
The ClinicalTrials.gov registry entry for NCT03165916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 514-participant average among 7 other Liver Transplant, Complications trials with a reported enrollment target (72% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant, Complications appearing as the primary indexed condition, and to 1 intervention - of which Bard 5 Fr diameter feeding tube is the first listed.
NCT03165916 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03165916 about?
NCT03165916 is a clinical study titled "Study to Compare the Incidence of Biliary Complications After Liver Transplantation". A randomized prospective study will be conducted of patients at Vanderbilt University Medical Center who undergo liver transplantation from March 2014 until approximately 120 patients are randomized. Patients will be randomized to undergo biliary reconstruction with and without stent placement.
What is the current status of trial NCT03165916?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2014-09-15. Estimated completion is 2019-09-30.
What conditions does trial NCT03165916 study?
This clinical trial studies the following conditions: Liver Transplant, Complications.
What interventions are being tested in trial NCT03165916?
The interventions under investigation include: Bard 5 Fr diameter feeding tube (DEVICE).
Who is sponsoring clinical trial NCT03165916?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03165916 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant, Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
-
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
RECRUITING · NA
-
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
RECRUITING · NA
-
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
RECRUITING · Phase 2
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RECRUITING
-
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.